All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Mon 1984-11-05? to Wed 2025-04-16 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
GSK × |
+4.24%
2025-04-16 |
16.1 TRR
2025-04-16 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Wed 2025-04-16 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
GSK × |
+1,509.92%
+7.11%/yr |
+5.20%/yr
(R2=0.681) |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Wed 2025-04-16 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
GSK × |
$10,000.00
1984-11-05 |
$160,992.26
2025-04-16 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Year | GSK |
---|---|
2025 (YTD) | +4.24% |
2024 | −7.80% |
2023 | +6.14% |
2022 | −23.23% |
2021 | +18.31% |
2020 | −18.89% |
2019 | +26.23% |
2018 | +11.55% |
2017 | −5.06% |
2016 | −0.11% |
2015 | −1.07% |
2014 | −16.40% |
2013 | +26.89% |
2012 | −1.15% |
2011 | +18.94% |
2010 | −3.64% |
2009 | +16.05% |
2008 | −22.39% |
2007 | −4.75% |
2006 | +5.24% |
2005 | +6.18% |
2004 | +2.21% |
2003 | +26.30% |
2002 | −23.48% |
2001 | −11.03% |
2000 | +0.66% |
1999 | −20.10% |
1998 | +45.80% |
1997 | +53.14% |
1996 | +14.03% |
1995 | +41.63% |
1994 | +0.25% |
1993 | −12.82% |
1992 | −25.13% |
1991 | +92.90% |
1990 | +22.86% |
1989 | +32.50% |
1988 | +2.45% |
1987 | +15.33% |
1986 | +37.66% |
1985 | +68.45% |
1984 | −1.91% |
Mon 1984-11-05? to Wed 2025-04-16 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
GSK × | −26.10% |
−60.55%
2009-03-09 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||